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Available online 16 November 2010Abstract Serum-free differentiation protocols of human embryonic stem cells (hESCs) offer the ability to maximize
reproducibility and to develop clinically applicable therapies. We developed a high-throughput, 96-well plate, four-color flow
cytometry-based assay to optimize differentiation media cocktails and to screen a variety of conditions. We were able to
differentiate hESCs to all three primary germ layers, screen for the effect of a range of activin A, BMP4, and VEGF
concentrations on endoderm and mesoderm differentiation, and perform RNA-interference (RNAi)-mediated knockdown of a
reporter gene during differentiation. Cells were seeded in suspension culture and embryoid bodies were induced to
differentiate to the three primary germ layers for 6 days. Endoderm (CXCR4+KDR–), mesoderm (KDR+SSEA-3–), and ectoderm
(SSEA-3+NCAM+) differentiation yields for H9 cells were 80±11, 78±7, and 41±9%, respectively. Germ layer identities were
confirmed by quantitative PCR. Activin A, BMP4, and bFGF drove differentiation, with increasing concentrations of activin
A inducing higher endoderm yields and increasing BMP4 inducing higher mesoderm yields. VEGF drove lateral mesoderm
differentiation. RNAi-mediated knockdown of constitutively expressed red fluorescent protein did not affect endoderm
differentiation. This assay facilitates the development of serum-free protocols for hESC differentiation to target lineages and
creates a platform for screening small molecules or RNAi during ESC differentiation.
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doi:10.1016/j.scr.2010.11.001Human embryonic stem cells (hESCs) offer the potential to
regenerate any cell in the human body. Initially, many studies
utilized serum-containing media to develop differentiation
protocols for target cell types (D'Amour et al., 2006; Kyba
et al., 2002; Reubinoff et al., 2000; Zambidis et al., 2005).
Serum, however, contains unknown and variable concentrations
of growth factors and proteins. More recently, serum-free
differentiation (SFD) protocols have emerged in order to.
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standing of biological pathways activated during differentiation
to specified lineages (Kennedy et al., 2007; Matsumoto et al.,
2009; Nakanishi et al., 2009; Park et al., 2004). Numerous
combinations of cytokines, growth factors, and siRNAmolecules
are being evaluated in order to understand signaling pathways
utilized during differentiation and to optimize differentiation
protocols to target cell types. By precisely activating or
inhibiting the TGFβ family, FGF, Wnt, and other pathways at
specific times, the developing embryo directs differentiation to
all somatic cells of the body (Gadue et al., 2005). In vitro hESC
differentiation systems attempt to recapitulate these
developmental pathways by utilizing controlled concentrations
of cytokines and inhibitors. As differentiation proceeds
down specific lineages, the possible number of cytokine
combinations dramatically increases. A high-throughput
screening method that streamlines the analysis of various
growth factor combinations and their effect on differentiation
would be extremely beneficial.
Only a few groups have developed small-scale ESC
differentiation systems in order to probe biological pathways
and optimize differentiation media cocktails. Ng et al. (Ng
et al., 2005, 2008) have developed a 96-well spin embryoid
body (EB) technique in which hESCs are spun down to form a
single EB of a defined size within each well. This technique
has been utilized to optimize differentiation to various
stages in the hematopoietic lineage (Pick et al., 2007; Davis
et al., 2008). Koike et al. have developed a 96-well murine
ESC (mESC) differentiation system and explored the effects
of EB seeding density on differentiation to cardiomyocytes
(Koike et al., 2005, 2007). Due to the small seeding density
utilized by both methods to generate single EBs and the
tendency for cell counts to drop over the first 5 days of
differentiation (Pick et al., 2007), it is unclear if enough cells
would be available for 96-well flow cytometry analyses
without pooling wells. Several studies have utilized an
adherent 384-well plate format to screen for small molecule
inhibitors or enhancers of ESC differentiation (Borowiak et
al., 2009; Desbordes et al., 2008). Although these confocal
microscopy-based assays have been utilized to screen several
thousand small molecules, they are not conducive to
multicolor flow cytometry or live cell sorting.
RNA interference (RNAi)-mediated gene knockdown has
also becomea common technique toexplore gene involvement
in active pathways. siRNA knockdown of reporter genes does
not affect pluripotency in hESCs grown on mouse embryonic
fibroblasts (MEFs) (Vallier et al., 2004). Knockdown of OCT4
and NANOG has been shown to induce differentiation and loss
of pluripotency in hESCs (Hay et al., 2004; Zaehres et al., 2005;
Rodriguez et al., 2007). RNAi has been utilized to elucidate
signaling pathways that mediate ESC differentiation to
multiple lineages (Izumi et al., 2007). Despite the potential
that RNAi offers for understanding biology and modifying
pathway activation, there are little data available regarding
any potential off-target effects this technique may have on
targeted hESC differentiation.
We have developed a small-scale, flow cytometry-based,
high-throughput hESC EB differentiation assay. In this study,
we differentiate hESCs to the three primary germ layers
and demonstrate biomarker profiles unique to each cell type.
We obtained high cell yields for each layer with remarkably low
well-to-well variability. We also demonstrate the abilityto perform small interfering RNA (siRNA)-mediated gene
knockdown at this scale without disrupting induced differenti-
ation. These results demonstrate the utility and efficacy of this
system for efficiently optimizing SFD conditions and performing
siRNA knockdown on numerous targets.Results
EB differentiation in a 96-well format
We optimized a 96-well plate, four-color flow cytometry assay
for analyzing surface markers during hESC EB differentiation
into target lineages. A stepwise EB differentiation protocol
was modified to differentiate the cells for 6 days (Fig. 1A)
(Yang et al., 2008). A four-color biomarker-based flow
cytometry assay to detect cells representative of all three
primary germ layers and undifferentiated hESCs in a single
sample was developed (Fig. 1B). Combinations of the surface
markers CXCR4, KDR, NCAM, and SSEA-3 were assessed to
distinguish each cell type. CXCR4 is a reliable marker for
definitive endoderm (Yasunaga et al., 2005), but is also
expressed in migrating mesoderm (McGrath et al., 1999). KDR
has frequently been utilized to characterize early mesoderm
prior to diverging to a KDR+ lateral lineage or a PDGFRα+
paraxial lineage (Nostro et al., 2008; Sakurai et al., 2006) and
is also expressed at low levels by hESCs (Yang et al., 2008).
SSEA-3 is a marker of pluripotency expressed by hESCs. On
differentiation, SSEA-3 expression is lost (Enver et al., 2005;
Kannagi et al., 1983), although expression is maintained at the
early neuroectoderm, neural stem cell stage (Pruszak et al.,
2007). NCAM (or CD56) is a neural marker whose expression is
induced during this early ectoderm stage (Pruszak et al., 2007)
and is a general marker for ectoderm differentiation (Park
et al., 2008). However, NCAM expression is not unique to
ectoderm but is expressed by some endoderm and mesoderm
cells as well (Lackie et al., 1994; Moller et al., 1992).
Therefore, we utilized SSEA-3+NCAM– expression to charac-
terize hESCs, CXCR4+KDR– expression for endoderm, SSEA-3+-
NCAM+ expression for ectoderm, and KDR+SSEA-3– expression
for mesoderm.
In order to examine interwell variability and percentage
differentiation, one 96-well plate was partitioned into three
induction media zones: endoderm, mesoderm, and ectoderm.
We utilized high activin A with bFGF to induce endoderm
(D'Amour et al., 2006), high BMP4 with bFGF to induce
mesoderm (Yang et al., 2008), and simultaneous activin
inhibition (SB431542) and BMP4 inhibition (BMP receptor 1A;
BMPR1A) with bFGF to induce ectoderm (Chambers et al.,
2009; Vallier et al., 2009) (Fig. 1B). The EBs appeared robust
and morphologically similar to those grown in bacterial grade
dishes and 6-well plates. A Ninety-six well flow cytometry was
performed and the different populations of cells were defined
from expression of the four biomarkers (Figs. 2A and B, Fig.
S1). HES2 endoderm (CXCR4+KDR–),mesoderm (KDR+SSEA-3–),
and ectoderm (SSEA-3+NCAM+) differentiation yields were 74±
9, 74±17, and 57±8%, respectively (Fig. 3E). H9 cells
demonstrated similar yields of 80±11, 78±7, and 41±9% for
endoderm, mesoderm, and ectoderm, respectively (Fig. 3F).
Interwell variability was remarkably low between identical
induction conditions (Figs. 3A–D), with standard deviations
consistently less than 4%. Activin-/BMP-inhibited media
Figure 1 Experiment schematic and differentiation model. (A) The 6-day stepwise hESC EB differentiation schematic. Differentiation
protocols were established in which cells were fed at Days 0, 1, and 4. Cells were seeded into 96-well plates at Day 1 and analyzed by
96-well flowcytometry atDay 6. (B) Differentiation and biomarker expressionmodel. A four-biomarker combinationwas designed inwhich
hESCs and cells representing the three primary germ layers could be analyzed in a single sample. Abbreviations: hESCs, human embryonic
stem cells; EB, embryoid body; SSEA-3, stage-specific embryonic antigen-3; CXCR, CXC chemokine receptor; KDR, kinase insert domain
receptor; NCAM, neural cell adhesion molecule; BMP, bone morphogenetic protein; bFGF, basic fibroblast growth factor.
131hESC differentiation screening assayretained expression characteristics of undifferentiated hESCs
(28±17% SSEA-3+NCAM–), although NANOG and OCT4 tran-
script expression indicated that this is likely due to retained
expression of SSEA-3 in non-NCAM expressing ectoderm
(Fig. 2C).
Cells displayed some toxicity after being seeded at Day 0
and then demonstrated proliferation after 2 days of differ-
entiation (Fig. S2). Both endoderm and mesoderm conditions
yielded 4- to 6-day cell counts similar to the initial seeding
density of 2×104 cells/well, indicating a potential popula-
tion plateau for these media. Ectoderm cell yields (Day 6 cell
counts compared to Day 0 seeding densities) were greater
than 300% at Day 6, possibly attributable to the addition of
20 ng/ml bFGF at Day 4. In order to evaluate the effect of
seeding density on differentiation efficiency, we evaluated
Day 6 marker expression levels for seeding densities of 8×103
to 6×104 cells/well (Fig. S3). The assay proved to be highly
robust for differences in cell densities. Undifferentiated
populations increased with increasing densities, as expected
due to nutrient and cytokine depletion. Mesoderm and
ectoderm differentiation efficiency showed a gradual de-
creasing trend with increasing seeding density, whereas
endoderm efficiency was essentially constant.
The differentiated populations of cells representative of
each primary germ layer, as well as undifferentiated hESCs,
display a unique biomarker profile (Figs. 3E and F). Each celltype was distinguished by increased expression of a
combination of biomarkers. These findings suggest that this
four-biomarker assay can be utilized to distinguish four unique
cell types after 6 days of differentiation. Furthermore, the
three differentiated cell types have a biomarker profile
characteristic of endodermal,mesodermal, or early ectodermal
cells.Gene expression verification of induced germ layers
In order to verify that the surface marker profiles obtained
using flow cytometry corresponded to the anticipated
lineages, real-time quantitative PCR (qPCR) was performed
on RNA harvested from Day 0 hESCs and from cells after
6 days of differentiation under the various differentiation
conditions. The pluripotency genes NANOG and OCT4 were
expressed in undifferentiated cells and as expected were
downregulated under the three conditions inducing cellular
differentiation (Fig. 2C). The anterior primitive streak gene
FOXA2 was drastically upregulated under the high activin
endoderm induction conditions, as were the anterior
definitive endoderm genes SOX17 and CER1 (Fig. 2D).
Fig. 2E displays characteristic gene expression profiles
representative of cells within the posterior primitive streak
and differentiating toward mesoderm. These genes were
132 J.T. Outten et al.upregulated under conditions using high BMP4, and are
representative of early stage as well as paraxial (PDGFRα)
and lateral progenitor mesoderm (GATA2) (Fig. 2E). Dual
BMP4 and activin A inhibition increased both PAX6 and SOX1
transcript expression (Fig. 2F). The neuronal marker NESTIN
was not upregulated under the ectoderm induction condi-
tions, indicating that these cells have not yet begun to
undergo neuralization (Lendahl et al., 1990). These gene
expression data support the flow cytometry profiles showing
that the three defined induction conditions differentiate the
cells into lineages representative of endodermal, mesoder-
mal, and early ectodermal germ layers.
Growth factor screening assay
We next sought to apply the 96-well flow cytometry assay to
efficiently screen specific growth factors across a range of
concentrations. The concentrations of three growth factors,
activin A (0–100 ng/ml), BMP4 (0–40 ng/ml), and VEGF
(± 10 ng/ml), were assessed for differentiation to endoderm
and mesoderm over the course of 6 days. The expression of
PDGFRαwas assessed for an additional mesodermal marker and
to indicate early progression toward the paraxial germ layer
(Sakurai et al., 2006). As discussed previously, SSEA3+,
CXCR4+KDR–, and KDR+SSEA-3– expression was used to indicate
undifferentiated cells and commitment of cells to endoderm
and mesoderm, respectively. As expected, expression of the
pluripotency marker, SSEA-3, steadily decreased under condi-
tions with increasing concentrations of activin and BMP4
(Fig. 4A). CXCR4+KDR– expression was nonexistent in the
absence of activin A, whereas a low concentration of activin A
(10 ng/ml) was sufficient to induce high (N60% of cells) CXCR4
expression (Fig. 4B). Increasing activin A from 10 to 100 ng/ml
increased CXCR4+KDR– expression for high BMP4 conditions, but
otherwise did not have a notable effect on CXCR4+KDR–
expression. For a constant activin A concentration, increasing
BMP4 consistently reduced CXCR4 expression. PDGFRα+ and
KDR+ populations were greatest in the absence of activin A
(Figs. 4C and D). Increasing the activin A concentration
immediately abrogated PDGFRα expression. Activin A and
BMP4 displayed a competitive relationship on KDR+SSEA-3–
expression. Increasing BMP4 concentration increased KDR
expression, whereas activin A consistently inhibited this
expression. Under most conditions, the additional supplemen-
tation of 10 ng/ml VEGF had no notable effect on the expression
of this set of cell surface markers (Figs. 4A–D).
These data suggest this 96-well flow cytometry assay can be
utilized to screen for the effect of a spectrum of growth factor
concentrations on hESC differentiation under serum-freeFigure 2 Biomarker time course and germ layer gene expression an
NCAM, CXCR4, and KDR surface marker expression levels were asse
differentiation flow cytometry profiles. Colored quadrants represent
(blue), ectoderm (yellow), and mesoderm (red). Similar mesoderm
profiles for all differentiation conditions over 6 days of differentiatio
or Day 6 and analyzed for genes characteristic of pluripotency (C), en
was normalized to the housekeeping gene GAPDH and all values are re
of three pooled wells from a single plate assay. Abbreviations: hESCs,
SSEA-3, stage-specific embryonic antigen-3; CXCR, CXC chemokine r
adhesion molecule; BMPR, bone morphogenetic protein receptor.conditions. Furthermore, increased concentrations of both
activin A and BMP4 reduce pluripotency. Increasing activin A
concentration increases CXCR4+KDR– endoderm populations
and reduces both KDR+SSEA-3– and PDGFRα+ mesoderm
populations. Conversely, increasing BMP4 concentration
increases KDR+SSEA-3– mesoderm populations but decreases
CXCR4+KDR– endoderm populations.Tracking germ layer differentiation through gene
expression kinetics
Kinetic analyses can also be performed during the differenti-
ation assays. Bykeeping BMP-4 constant at 10 ng/ml, four of the
previously screened induction conditions were chosen in which
two were optimal for endoderm (activin A at 20±10 ng/ml
VEGF) and two were optimal for mesoderm (activin A at 0±
10 ng/ml VEGF). All conditions were carried out on a single
96-well plate. Gene expression profiles were determined from
cells obtained during the 6 days of differentiation. Genes
expressed during mesoderm and endoderm induction were
analyzed, with the inclusion of OCT4 as a marker of
pluripotency in undifferentiated cells.
Mesoderm genes (KDR, PDGFRα, MEOX1, CD34) were
consistently expressed at higher levels in the absence of activin
A while endoderm genes (FOXA2, CXCR4, SOX17) were
consistently expressed in the presence of activin A (Fig. 5).
OCT4 expression steadily decreased under all conditions over
the 6-day period. Brachyury expression peaked rapidly at Days
2–4 and then decreased in all samples, indicative of ESCs
passing through the primitive streak stage (Fehling et al., 2003;
Gadue et al., 2006; Wang and Nakayama, 2009). Additionally,
non-activin A conditions demonstrated a clear progression
through a Brachyury+KDR– stage to a Brachyury+KDR+ stage,
indicative of premesoderm to mesoderm/hemangioblast
differentiation (Nostro et al., 2008; Fehling et al., 2003).
PDGFRα is a marker of mesendoderm (Tada et al., 2005) and
was expressed in all samples at Day 4 followed by increased
expression in mesoderm inducing conditions. CXCR4, while
expressed 100-fold higher in the activin A conditions, was still
upregulated 10-fold in the absence of activin A when compared
to undifferentiated cells. This is to be expected since CXCR4 is
not entirely endoderm specific but is also expressed by
migrating mesoderm (McGrath et al., 1999). This result is
consistent with CXCR4 protein expression detected by flow
cytometry (Fig. S1A). Generally, the addition of VEGF had no
notable effect on gene expression,with the exception of lateral
(CD34) and paraxial (PDGFRα) specific genes. The expression of
CD34, a lateral mesoderm and hematopoietic cell marker, wasalyses. Germ layer differentiation was initiated at Day 0. SSEA-3,
ssed with flow cytometry at Days 0, 2, 4, and 6. (A) Endoderm
undifferentiated cells (brown) and differentiation to endoderm
and ectoderm plots are given in Fig. S1. (B) Marker expression
n. (C–F) RNA was prepared from cells harvested at Day 0 (hESCs)
doderm (D), mesoderm (E), or ectoderm (F) by qPCR. Expression
lative to hESC expression at Day 0. Error bars represent mean±SD
human embryonic stem cells; BMP, bone morphogenetic protein;
eceptor; KDR, kinase insert domain receptor; NCAM, neural cell
133hESC differentiation screening assayinduced in the absence of activin A but only in the presence of
VEGF. Conversely, the expression of the paraxial gene,
PDGFRα, was highest in the absence of activin and VEGF,
indicating that VEGF drives lateral or hematopoietic differen-
tiation (Sakurai et al., 2006).siRNA knockdown during endoderm differentiation
In addition to the amount of information that can be derived
using this 96-well format in optimizing growth factor conditions
and kinetics, this format is ideal as a high-throughput siRNA
Figure 3 Day 6 phenotypes after differentiation to the three germ layers. (A–D) Interwell variability for 96-well flow cytometry
expression profiles. hESCs were seeded into a 96-well plate and differentiated to endoderm, mesoderm, or ectoderm. Cells were
stained for SSEA-3, CXCR4, NCAM, and KDR after 6 days to assess interwell variability and the ability to distinguish the separate germ
layers. Plots show percentages of cells expressing the designated surface marker. (E–F) Biomarker profiles for HES2 and H9
differentiation. Each of the four cell types (hESCs, endoderm, mesoderm, ectoderm) was characterized by a unique biomarker
expression profile. The 96-well format demonstrated highly efficient differentiation to all three lineages. Error bars represent well
means of (E) two independent experiments (n=2)±SD and (F) three independent experiments (n=3)±SD. Each germ layer was
significantly different for its appropriate biomarker at the Pb0.01 level (Student's t test). Abbreviations: hESCs, human embryonic
stem cells; SSEA-3, stage-specific embryonic antigen-3; CXCR, CXC chemokine receptor; KDR, kinase insert domain receptor; NCAM,
neural cell adhesion molecule; BMPR, bone morphogenetic protein receptor.
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verify that siRNA knockdown can be achieved in this 96-well
format without disrupting differentiation, hESCs that constitu-
tively express an RFP protein (Irion et al., 2007) were utilized.
These cells were induced to differentiate using endoderm
conditions and transfected with a siRNAmolecule targeting the
RFP mRNA at day 1. Following 6 days of differentiation, cells
were analyzedusing flow cytometry andqPCR. Both control and
mock-treated cells vividly fluoresced after 6 days, whereas
cells exposed to the siRFP molecule only expressed very low
levels of fluorescence (Fig. 6A). To evaluate RFP proteinexpression during endoderm induction, both RFP and CXCR4
expressions were analyzed using flow cytometry (Fig. 6B).
Approximately 85% of both the control cells and the cells
transfected with scrambled siRNA were RFP+, compared to 4%
of the cells transfected with siRNA targeted to RFP. Under all
conditions, 75–80% of the cells were CXCR4+, with no notable
decrease caused by siRFP knockdown. To further verify that
siRNA knockdown had not altered endoderm differentiation,
qPCR analysis was performed after 6 days of differentiation
(Fig. 6C) to analyze RFP expression and the anterior primitive
streak/definitive endoderm markers FOXA2 and CER1. RFP
Figure 4 A 96-well plate growth factor screening analysis. Activin A, BMP4, and VEGF concentrations were varied over a 96-well
plate and SSEA-3+ (A), CXCR4+KDR– (B), PDGFRα+ (C), and KDR+SSEA-3– (D) expression levels were analyzed using flow cytometry after
6 days of differentiation. All samples contained bFGF (Days 1–4, 2.5 ng/ml; Days 4–6, 5 ng/ml). VEGF concentration was±10 ng/ml.
(A) Pluripotency decreased with increasing activin A and BMP4. (B) Endoderm populations increased with increasing activin A and
decreased with increasing BMP4. (C, D) Mesoderm character was highest in the absence of activin A. PDGFRa+ mesoderm was only
detectable with no activin. KDR+SSEA-3– mesoderm populations consistently increased with increasing BMP4 concentration and
decreasing activin A concentration. All concentrations are ng/ml. Error bars represent the mean of two wells±SD from a single plate
assay. Abbreviations: SSEA-3, stage-specific embryonic antigen-3; CXCR, CXC chemokine receptor; KDR, kinase insert domain
receptor; PDGFRα, platelet-derived growth factor-α; BMP, bone morphogenetic protein; VEGF, vascular endothelial growth factor.
135hESC differentiation screening assaytranscript expression decreased by 96% as a result of siRNA
knockdown. Neither FOXA2 nor CER1 expression were notably
influenced by siRNA knockdown. These data suggest that siRNA
knockdown can be performed in a 96-well format without
significantly altering targeted differentiation.Discussion
Serum-free and feeder-free hESCs differentiation protocols
are essential in order to (1) maximize experimental control
and reproducibility and (2) develop clinically applicable
regenerative therapies (Chase and Firpo, 2007). Many studies
have focused on titrating growth factors and inhibitors within
SFD cocktails to optimize target cell differentiation. As
lineages are further explored, the possible combinations of
factors will inevitably rise. Screening assays are extremely
effective in this pursuit. We have developed a high-
throughput, multicolor flow cytometry assay of hESC
differentiation that can be utilized to assess a range of SFD
conditions. This small-scale format requires approximately
92% less reagents and growth factors than 6-well culture
conditions and occupies 6% of the incubator space. Addition-ally, this assay utilizes surface markers to allow for live-cell
analysis and sorting.
We differentiated hESCs to the three primary germ layers
in this system, identified extracellular biomarker profiles for
each, and confirmed germ layer identity with gene
expression analysis. A wide variety of extra- and intracel-
lular markers have been previously utilized to identify each
of the primary germ layers. Given the heterogeneous
expression patterns of endoderm, mesoderm, and ecto-
derm, no four-marker combination will perfectly distinguish
all cells within each lineage. CXCR4 is expressed in migrating
early endoderm and mesoderm (McGrath et al., 1999),
developing vascular endothelial cells (Tachibana et al.,
1998), and migrating neural stem cells (Imitola et al., 2004).
Although typically 20–25% of mesodermal cells expressed
CXCR4, our results showed that endoderm was uniquely
distinguishable by CXCR4+KDR– expression at this stage of
differentiation. KDR is expressed on mesoderm cells after
exiting the primitive streak (Ema et al., 2006) and has been
utilized to characterize hESC differentiation to general
mesoderm as well as vascular and cardiac progenitors
(Nostro et al., 2008; Sakurai et al., 2006; Kattman et al.,
2006). Although our results corresponded with previous
Figure 5 Gene expression kinetic analysis. Four conditions (10 ng/ml BMP4, ± 20 ng/ml activin A, ± 10 ng/ml VEGF) were chosen from the results of the growth factor screening
experiment (Fig. 4) and analyzed for transcript expression levels during the 6-day differentiation procedure. Pluripotency (OCT4) decreased over differentiation and Brachyury
expression peaked between 2 and 4 days. Endoderm genes (FOXA2, CXCR4, SOX17) were expressed much higher for conditions supplemented with activin A, whereas mesoderm gene
expression (KDR, PDGFRα, MEOX1, CD34) was highest for non-activin A conditions. VEGF increased CD34 and decreased PDGFRα expression at late time points. Expression was
normalized to the housekeeping gene GAPDH and all values are relative to hESC expression at Day 0. Error bars represent mean±SD of three pooled wells from a single plate assay.
Abbreviations: hESCs, human embryonic stem cells; SSEA-3, stage-specific embryonic antigen-3; CXCR, CXC chemokine receptor; KDR, kinase insert domain receptor; NCAM, neural cell
adhesion molecule; BMP, bone morphogenetic protein; VEGF, vascular endothelial growth factor.
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Figure 6 siRNA-mediated RFP knockdown during endoderm differentiation. hESCs were reverse-transfected with siRFP or a scrambled
control when seeded into a 96-well plate format and induced to form endoderm in high activin A SFDmedia. (A) Fluorescencemicroscopy
of Day 6 EBs. (B) Flow cytometry of Day 6 cells showing RFP (y-axis) vs CXCR4 (x-axis) expression. CXCR4 expression was not diminished by
siRNA-induced RFP knockdown. (C) Gene expression analysis. qPCRwas performed at Day 6 to analyze RFP transcript expression as well as
the endoderm genes FOXA2 and CER1. RFP knockdown had no notable effect on endoderm differentiation. Error bars represent mean±SD
of three pooled wells from a single plate assay. Abbreviations: EBs, embryoid bodies; RFP, red fluorescent protein; SFD, serum-free
differentiation; CXCR, CXC chemokine receptor.
137hESC differentiation screening assaystudies that have found KDR expression in a portion of hESCs
(Yang et al., 2008), mesodermal cells generated by high
BMP4 conditions were uniquely identifiable by KDR+SSEA-3–
expression. Currently, no well-characterized extracellular
early ectoderm surface markers have been validated.
Ectoderm has typically been characterized by the intracel-
lular markers Nestin, β-III Tubulin, or Sox1 (Vallier et al.,
2009; King et al., 2009; Nakagawa et al., 2008; Parekkadan
et al., 2008; Smith et al., 2008; Watanabe et al., 2005). Weexploited the delayed expression of SSEA-3 into the early
neural stem cell stage (Pruszak et al., 2007) to overcome the
confounding NCAM expression in endoderm and mesoderm.
Transcript expression indicated that this stage is similar to
the primitive anterior neuroectoderm/neuroepithelia stage
defined by Pankratz et al. (Pankratz et al., 2007), namely
that PAX6 expression is upregulated with SOX1 expression
beginning to increase. This strategy carries the caveat that
SSEA-3+NCAM+ phenotyping would not be applicable at a
138 J.T. Outten et al.later stage in the ectoderm lineage due to the loss of SSEA-3
expression.
Although exact comparisons are difficult to make due to
various time points, markers utilized, data reported, and host
species differences, we obtained excellent yields in relation to
previous studies. Serum-containing, high activin A protocols
have produced SOX17+ endoderm yields ranging from 55%
(Borowiak et al., 2009) to greater than 80% (D'Amour et al.,
2005) after 5–6 days of differentiation in hESCs. Our yield of
80% for H9 cells falls within the higher range of this spectrum.
Day 6 KDR+ mesoderm populations of 15–25% (Goldman et al.,
2009) and 52% (Zhang et al., 2008) cells have been obtained
from hESCs. We obtained greater than 74% KDR+SSEA-3–
mesoderm yields for multiple hESC lines. Patani et al.
generated Day 4 and Day 8 yields of 51% and approximately
80%, respectively, for cells positive for the neuroectoderm
marker MUSASHI from hESCs (Patani et al., 2009). Chambers et
al. generated greater than 80% HES5+ neuroectoderm after
11 days of hESC differentiation (Chambers et al., 2009). Our 6-
day protocol generated yields of 41–57%, comparable to these
studies given the shorter time duration.
Many cytokine conditions, small molecules, and transfec-
tion conditions may induce cellular toxicity. Additionally,
seeding densities may be highly variable due to the inability to
seed hESCs as single cell suspensions in many lines. It is vital to
obtain consistent and reliable results from a screening assay
despite these caveats. This small-scale culture system
demonstrated remarkable interwell repeatability and density
robustness, particularly since static EB differentiation systems
have been reported to generate highly heterogeneous cell
populations (Carpenedo et al., 2007). Since 96- and 384-plate
assays can display variations due to edges, evaporation,
thermal variations, and pipetting error (Armknecht et al.,
2005; Barker and Diamond, 2008; Faessel et al., 1999), we
utilized gas-permeable membranes and stainless-steel lids to
minimize evaporation and ensure a uniform heat distribution
(Lucumi et al., 2010). All standard deviationswere less than 4%
for biomarker signals, which allowed for highly significant
differences between conditions.
Whilemany studies haveutilized siRNAas a tool for studying
ESC differentiation, there are limited data reporting the
presence or absence of off-target siRNA effects on differen-
tiation outcome. Nonviral transfection of off-target siRNA
molecules has been found to induce adipogenesis in human
mesenchymal stem cells (Xu et al., 2007). Hence, it is
important to measure the effects that transfection or
transduction may induce in ESC differentiation protocols. We
found that siRNA-mediated knockdown of constitutively
expressed RFP was highly efficient and induced no notable
effects on endoderm differentiation. Cells were transfected
with the siRNA molecules at Day 1 of differentiation and
exhibited significant RFP knockdown at Day 6. This assay
provides a siRNA screening platform that can potentially be
utilized for differentiation pathway analysis.
In an effort to demonstrate the efficiency and power of
this 96-well assay system, we conducted a growth factor
screening assay utilizing a single 96-well plate and analyzed
32 conditions in duplicate. We then extended the capabil-
ities of this small-scale system to analyze time-course gene
expression profiles for four of these conditions, again, within
a single 96-well plate. bFGF in combination with activin A or
BMP4 drove differentiation and reduced pluripotency. Inparticular, the greatest number of CXCR4+KDR– cells was
induced by low to high activin A with no BMP4. Gene profiles
over the 6-day time period for the activin A+BMP4 conditions
confirmed that these CXCR4+KDR– cells were characteristic
of definitive endoderm. These results correspond to previous
studies that found increased CXCR4 expression and increased
definitive endoderm yields by differentiating cells under high
activin A containing SFD conditions (D'Amour et al., 2005;
Yao et al., 2006). Our results are similar to those of Vallier et
al. in which high activin A in combination with bFGF and
BMP4 induced mesendoderm (Vallier et al., 2009). Several
studies have previously reported that activin A+bFGF blocks
differentiation and maintains pluripotency (Vallier et al.,
2009; Xiao et al., 2006), whereas our results demonstrated
increased endoderm production. Our protocol includes a
BMP4 exposure step at Day 0–1 to serve as a “jumpstart” to
differentiation. The decrease in pluripotent marker expres-
sion in subsequent activin A + bFGF SFD conditions is likely
attributable to this step. Activin A and BMP4 exhibited a
competitive effect on mesoderm marker expression. The
presence of activin A alone eliminated PDGFRα expression at
Day 6, although all samples demonstrated transcript expression
through the Day 2–4 primitive streak stage. This PDGFRα
reducing effect of activin A has been previously observed
(Vallier et al., 2009). Similarly, activin A reduced KDR+SSEA-3–
expression,with highest expression levels seenunder highBMP4
SFD conditions with no activin A. These results also corroborate
previous studies that have induced mesoderm and vascular
progenitors through BMP4 activation (Park et al., 2004; Bai et
al., 2010) and noted reduced KDR expression with increasing
activin A supplementation (Yang et al., 2008; Nostro et al.,
2008; Vallier et al., 2009).
The addition of VEGF to SFD had no notable effect on surface
marker expression at Day 6. However, CD34 transcript
expression increased and PDGFRα expression decreased,
indicating a role in inducing early mesoderm cells toward a
hematopoietic lineage. Indeed, several studies have utilized
VEGF to induce mesendoderm or mesoderm progenitors toward
a hematopoietic or cardiovascular state (Pick et al., 2007; Yang
et al., 2008; Narazaki et al., 2008), and VEGF inclusion has been
shown to improve subsequent hematopoietic blast colony
formation (Nostro et al., 2008).
Elucidating the optimal serum-free protocols for EB
differentiation of hESCs will require exploring a vast
combinatorial field of growth factors, inhibitors, and
cytokines. This small-scale culture platform and live-cell
flow assay provides a more efficient and more cost-effective
approach to analyzing a large number of conditions. It can
additionally be utilized to discover biological pathways or
optimize differentiation through RNAi or miRNA screens. By
varying biomarkers, this assay can be adopted to various
stages of lineage differentiation to significantly enhance
progress toward hESC-derived clinical therapies.Materials and methods
hESC maintenance
HES2 (passage 26–34) and H9 cells (passage 35–45) were
maintained on irradiatedmouse embryonic fibroblasts (MEFs) in
DMEM/F12 50/50 (Mediatech) supplementedwith 20% Knockout
139hESC differentiation screening assaySerum (Invitrogen, Carlsbad, CA), 1X nonessential amino acids
(Invitrogen), 0.55 mM β-mercaptoethanol, 1% penicillin/strep-
tomycin, 2 mM glutamine (Invitrogen), and 20 ng/ml bFGF (R&D
Systems, Minneapolis, MN). Cells were passaged at 1:3–1:6
ratios using 0.25% trypsin/EDTA (Mediatech, Manassas, VA). For
siRNA experiments, a previously established HES2 line was
utilized that expresses a red fluorescent protein (RFP) from the
hROSA26 locus (HES2-R26) (Irion et al., 2007).
hESC differentiation
A 6-day differentiation procedure was utilized (Fig. 1A).
Prior to differentiation, hESCs were trypsinized and replated
on matrigel (Becton Dickinson, Franklin Lakes, NJ). SFD
medium consisted of 75% IMDM (Invitrogen), 25% F12
(Mediatech), 0.5X N-2 supplement (Invitrogen), 0.5X B27
without retinoic acid (Invitrogen), and 0.05% BSA (Sigma, St.
Louis, MO). On 75% confluency, cells were trypsinized,
harvested with a cell scraper, spun down, and resuspended
in SFD medium supplemented with penicillin/streptomycin,
2 mM glutamine, 0.5 mM ascorbic acid (Sigma), 1.5×10-4 M
monothioglycerol (Sigma), and the specified concentrations
of cytokines as indicated (summarized in Table 1). Day 0
media were supplemented with 10 ng/ml BMP4 (R&D
Systems) for endoderm/mesoderm or 10 μM SB431542
(Tocris, Ellisville, MO), 500 ng/ml BMPR1A (R&D Systems),
and 5 ng/ml bFGF (R&D Systems, Minneapolis, MN) for
ectoderm. Cells (2×106) were seeded into 10-cm petri dishes
and cultured at 5% CO2/5% O2/90% N2. After 24 h, EBs were
harvested, manually disrupted, and seeded into 100 μl Day 1
medium into low-cluster 96-well plates (Corning, Corning,
NY) at 2×105 cells/ml (2×104 cells/well). Endoderm Day 1
medium was supplemented with 100 ng/ml activin A (R&D
Systems), 2.5 ng/ml bFGF, 0.5 ng/ml BMP4. Mesoderm Day 1
medium was supplemented with 0.5 ng/ml activin A, 2.5 ng/Table 1 Differentiation media
Day 0 Day 1
Endoderm •2 mM glutamine (Invitrogen)
•0.5 mM ascorbic acid (Sigma)
•1.5×10-4 M monothioglycerol (Sigma)
•10 ng/ml BMP4 (R&D Systems)
•2 mM g
•0.5 mM
•1.5×10
•0.5 ng/
•100 ng/
•2.5 ng/
Mesoderm Identical to Day 0 endoderm •2 mM g
•0.5 mM
•1.5×10
•20 ng/m
•0.5 ng/
•2.5 ng/
Ectoderm •2 mM glutamine
•0.5 mM ascorbic acid
•1.5×10-4 M monothioglycerol
•500 ng/ml BMPR1A (R&D Systems)
•10 μM SB431542 (Tocris)
•5 ng/ml bFGF
Identicalml bFGF, and 20 ng/ml BMP4. Ectoderm Day 1 medium was
supplemented with 5 ng/ml bFGF, 10 μM SB431542, and
500 ng/ml BMPR1A. For growth factor screening experi-
ments, Day 1 media contained 2.5 ng/ml bFGF, and activin A
and BMP4 were utilized at concentrations of 0 to 100 ng/ml,
as indicated. At Day 4, 200 μl of Day 4 media was added to
each well. Day 4 mesoderm and endoderm media were
identical to Day 1 media, but with 5 ng/ml bFGF. Day 4
ectodermmedium was identical to Day 1 medium with 20 ng/
ml bFGF. For growth factor screening experiments, media
were supplemented with 5 ng/ml bFGF, the indicated
concentrations of activin A and BMP4, and±10 ng/ml VEGF
(R&D Systems). During incubation, 96-well plates were
covered with gas-permeable membranes (Breathe Easy,
Diversified Biotech, Boston, MA) and stainless-steel plate
lids (Kalypsys, Inc., San Diego, CA).
Ninety-six well flow cytometry
EBs were dissociated with 0.25% trypsin/EDTA. Antibodies
utilizedwere as follows: rat anti-SSEA-3-Alexa 488 (Biolegend,
San Diego, CA, 330306), mouse anti-CXCR4-PE (Invitrogen,
MHCCXCR404), mouse anti-NCAM-PE/Cy7 (Biolegend,
318318), mouse anti-KDR-Alexa 647 (Biolegend, 338909),
mouse anti-PDGFRα-biotin (Biolegend, 323503), and strepta-
vidin-PE/Cy7 (Invitrogen, SA1012). Cells were acquired
directly from 96-well plates using a C6 flow cytometer
equipped with a 96-well plate C-Sampler (Accuri, Ann Arbor,
MI) and analyzed using CFlow Plus software (Accuri) or FlowJo
(Treestar, Ashland, OR).
Real-time quantitative PCR
EBs were collected from wells and dissociated with 0.25%
trypsin/EDTA. Cells were lysed with the facilitation ofDay 4
lutamine
ascorbic acid
-4 M monothioglycerol
ml BMP4
ml activin A (R&D Systems)
ml bFGF (R&D Systems)
•2 mM glutamine
•0.5 mM ascorbic acid
•1.5×10-4 M monothioglycerol
•0.5 ng/ml BMP4
•100 ng/ml activin A
•5 ng/ml bFGF
lutamine
ascorbic acid
-4 M monothioglycerol
l BMP4
ml activin A
ml bFGF
•2 mM glutamine
•0.5 mM ascorbic acid
•1.5×10-4 M monothioglycerol
•20 ng/ml BMP4
•0.5 ng/ml activin A
•5 ng/ml bFGF
to Day 0 ectoderm •2 mM glutamine
•0.5 mM ascorbic acid
•1.5×10-4 M monothioglycerol
•500 ng/ml BMPR1A
•10 μM SB431542
•20 ng/ml bFGF
140 J.T. Outten et al.QiaShredder columns and RNA was harvested using an RNeasy
Mini-kit and treated with RNase-free DNase (Qiagen, Valencia,
CA). Reverse transcription was performedwith the iScript cDNA
synthesis kit (Bio-Rad, Hercules, CA) or the High Capacity cDNA
Reverse Transcription kit (Applied Biosystems). Real-time
quantitative PCR (qPCR) was performed in triplicate on a
Roche Lightcycler 480 using LightCycler 480 SYBR Green I
master mix (Roche, Indianapolis, IN) and 500 nM primer
concentrations (Table S1). All gene expression levels were
normalized to the housekeeping geneGAPDH (Pick et al., 2007).
siRNA knockdown
HES2 cells stably expressing RFP (HES2-R26 cells) (Irion et al.,
2007) were reverse-transfected at the time of 96-well plate
seeding at Day 1. Cells (2×104) in 100 μl of Day 1 endoderm
media were seeded onto a 20 μl transfection volume of
Optimem I Reduced Serum Media (Invitrogen) containing
0.2 μl RNAiMax per well (Invitrogen) and 10 nM of either a
nonspecific scramble siRNA (Applied Biosystems, Foster City,
CA) or a siRNA designed to target the RFP mRNA (IDT,
Coralville, IA). Day 1 total well volume was thus 120 μl.
Control samples were seeded into Optimem Media. RNAiMax
was utilized due to its high efficiency of delivering siRNA into
hESCs (Zhao et al., 2008). Differentiation was performed as
previously described, in which 200 μl medium at Day 4 was
subsequently added to each well.
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.scr.2010.11.001.Acknowledgments
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